About Mercy Research Institute
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Pfizer
3
Angel Medical Systems
1
Columbia University
1
Hoffmann-La Roche
1
Puma Biotechnology, Inc.
1
University of Maryland, Baltimore
1
Clinical Trials at Mercy Research Institute
During the past decade, Mercy Research Institute conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 5 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Warfarin Versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial
2002-10-01
2014-07-01
Completed
2,305
0822GCC: Phase 2 Study of Efficacy and Safety of Apricoxib/Placebo With Docetaxel or Pemetrexed in Non-Small Cell Lung Cancer
2008-11-01
2014-12-01
Completed
109
Study Evaluating Neratinib Versus Lapatinib Plus Capecitabine For ErbB2 Positive Advanced Breast Cancer
2009-02-04
2018-06-03
Completed
233
Comparison Of 2 Doses Of Temsirolimus (Torisel) In Patients With Mantle Cell Lymphoma
2011-03-01
2018-06-01
Completed
101
A Study Of Inotuzumab Ozogamicin Plus Rituximab For Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma Patients Who Are Not Candidates For Intensive High-Dose Chemotherapy
2011-04-04
2014-03-28
Terminated
338
A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis
2011-08-31
2022-12-31
Completed
821
A Study Of Two Dual PI3K/mTOR Inhibitors, PF-04691502 And PF-05212384 In Patients With Recurrent Endometrial Cancer
2012-01-19
2015-12-25
Terminated
67
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Mercy Research Institute" #1 sponsor was "Pfizer" with 3 trials, followed by "Angel Medical Systems" with 1 trials
sponsored, "Columbia University" with 1 trials sponsored, "Hoffmann-La Roche" with 1 trials sponsored and "Puma Biotechnology, Inc."
with 1 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Mercy Research Institute"
#1 collaborator was "National Institute of Neurological Disorders and Stroke (NINDS)" with 1 trials as a collaborator, "Symbios Clinical" with 1 trials as a collaborator, "Tragara Pharmaceuticals, Inc." with 1 trials as a collaborator and "UCB Pharma" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Mercy Research Institute
According to Clinical.Site data, the most researched conditions in "Mercy Research Institute" are
"Acute Coronary Syndrome" (1 trials), "Acute Myocardial Infarction (AMI)" (1 trials), "Advanced Breast Cancer" (1 trials), "Breast Cancer" (1 trials) and "Coronary Occlusion" (1 trials). Many other conditions were trialed in "Mercy Research Institute" in a lesser frequency.
Clinical Trials Intervention Types at Mercy Research Institute
Most popular intervention types in "Mercy Research Institute" are "Drug" (7 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Capecitabine" (1 trials), "Docetaxel or Pemetrexed" (1 trials), "Guardian System" (1 trials), "Inotuzumab ozogamicin" (1 trials) and "Interferon beta-1a" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Mercy Research Institute
The vast majority of trials in "Mercy Research Institute" are
6 trials for "All" genders and 2 trials for "Female" genders.
Clinical Trials Status at Mercy Research Institute
Currently, there are NaN active trials in "Mercy Research Institute".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in Mercy Research Institute,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Mercy Research Institute, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".